Burnham Asset Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
$3.79M Sell
114,150
-10,800
-9% -$370K 1.06% 26
2016
Q1
$3.7M Sell
124,950
-1,410
-1% -$38.9K 1.18% 21
2015
Q4
$3.33M Hold
126,360
0.91% 36
2015
Q3
$2.99M Buy
126,360
+24,000
+23% +$579K 0.79% 37
2015
Q2
$2.43M Buy
102,360
+78,000
+320% +$1.76M 0.56% 53
2015
Q1
$578K Hold
24,360
0.13% 154
2014
Q4
$517K Hold
24,360
0.12% 160
2014
Q3
$415K Buy
24,360
+1,200
+5% +$18.9K 0.09% 185
2014
Q2
$331K Hold
23,160
0.07% 202
2014
Q1
$286K Hold
23,160
0.07% 218
2013
Q4
$254K Sell
23,160
-120,000
-84% -$1.35M 0.06% 224
2013
Q3
$1.66M Hold
143,160
0.41% 72
2013
Q2
$1.6M Buy
+143,160
New +$1.69M 0.41% 69

Other funds holding EW

Burnham Asset Management's EW Position: Q2 2016 in Review

Burnham Asset Management reduced its Edwards Lifesciences (EW) stake by 8.6% in Q2 2016, selling an estimated $370K and leaving 114,150 shares worth $3.79M. The position accounts for 1.06% of the portfolio, ranked #26.

Burnham Asset Management first reported a position in EW in Q2 2013 and has held it in 13 quarters since. 692 funds tracked by Wall St. Rank hold EW as of Q2 2016.

  • Burnham Asset Management held 114,150 shares of Edwards Lifesciences worth $3.79M as of Q2 2016.
  • Burnham Asset Management sold 10,800 Edwards Lifesciences shares in Q2 2016, an estimated $370K.
  • Edwards Lifesciences made up 1.06% of Burnham Asset Management's portfolio in Q2 2016, its #26 holding.
  • Burnham Asset Management first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 13 quarters since.
  • 692 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2016.

Based on Burnham Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.